Top

Osteoporosis International

Published in:

01-10-2006 | Original Article

Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients

Authors: M. Inaba, S. Okuno, Y. Imanishi, S. Yamada, A. Shioi, T. Yamakawa, E. Ishimura, Y. Nishizawa

Published in: Osteoporosis International | Issue 10/2006

Abstract

Introduction:

Fibroblast growth factor (FGF) 23 is a recently identified circulating factor that regulates phosphate (Pi) metabolism. Since the derangement of Pi control is an important risk factor for vascular calcification, we investigated the importance of plasma FGF-23 in the development of vascular calcification in the aorta and peripheral artery in hemodialysis patients with and without diabetes mellitus (DM).

Methods:

Male hemodialysis patients with DM (n=32) and without DM (n=56) were examined. Plasma samples were obtained before the start of dialysis sessions, and the FGF-23 levels were determined by enzyme-linked immunosorbent assay. Roentgenography of the aorta and hand artery was performed, and visible vascular calcification was evaluated by one examiner, who was blinded to the patient characteristics.

Results:

In the 56 non-DM hemodialysis patients, vascular calcification was found in the hand artery in 5 patients (8.9%) and in the aorta in 23 patients (41.1%). These levels were significantly lower (p<0.05) than in the 32 DM patients, of whom, 19 (59.4%) and 21 (65.6%) had vascular calcification of the hand artery and aorta, respectively. Multiple regression analyses performed separately in the non-DM and DM patients showed that the plasma FGF-23 level, Ca×Pi product, and body weight are independent factors significantly associated with hand-artery calcification and that diastolic blood pressure is associated with aorta calcification in non-DM patients. In DM patients, the plasma FGF-23 level and hemodialysis duration emerged as independent factors associated with hand-artery calcification and diastolic blood pressure was associated with aorta calcification. The independent association of the plasma FGF-23 level with hand-artery calcification was retained in both non-DM and DM patients when adjusted for the Ca×Pi product.

Conclusion:

Our findings show that the plasma FGF-23 level is an independent factor negatively associated with peripheral vascular calcification in the hand artery, but not in the aorta, in both male non-DM and DM hemodialysis patients, even when adjusted for the Ca×Pi product. This study raises the possibility that the plasma FGF-23 level may provide a reliable marker for Moenckeberg’s medial calcification in male hemodialysis patients, independent of its regulatory effect on Pi metabolism.

Davies MR, Fruska KA (2001) Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 60(2):472–479PubMedCrossRef

Cozzolino M, Dusso AS, Slatopolsky E (2001) Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol 12(11):2511–2516PubMed

Ishimura E, Okuno S, Kitatani K, Kim M, Shoji T, Nakatani T, Inaba M, Nishizawa Y (2002) Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients—importance of glycaemic control. Diabetologia 45(10):1446–1448PubMedCrossRef

Taniwaki H, Ishimura E, Tabata T, Tsujimoto Y, Shioi A, Shoji T, Inaba M, Inoue T, Nishizawa Y (2005) Aortic calcification in haemodialysis patients with diabetes mellitus. Nephrol Dial Transplant 20(11):2472–2478PubMedCrossRef

Ishimura E, Okuno S, Kitatani K, Maekawa K, Izumotani T, Yamakawa T, Jono S, Shoji T, Shioi A, Inaba M, Massry SG, Nishizawa Y (2004) C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries. Semin Nephrol 24(5):408–412PubMedCrossRef

Yamashita T, Yoshioka M, Itoh N (2000) Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 277(2):494–498PubMedCrossRef

Yamashita T, Konishi M, Miyake A, Inui K, Itoh N (2002) Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway. J Biol Chem 277(31):28265–28270PubMedCrossRef

Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, Yoshihara A, Miura M, Miyauchi A, Kobayashi K, Miki T, Shoji T, Ishimura E, Nishizawa Y (2004) FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 65(5):1943–1946PubMedCrossRef

Imel EA, Econs MJ (2005) Fibroblast growth factor 23: roles in health and disease. J Am Soc Nephrol 16(9):2565–2575PubMedCrossRef

10.

Gupta A, Winer K, Econs MJ, Marx SJ, Collins MT (2004) FGF-23 is elevated by chronic hyperphosphatemia. J Clin Endocrinol Metab 89(9):4489–4492PubMedCrossRef

11.

Mirams M, Robinson BG, Mason RS, Nelson AE (2004) Bone as a source of FGF23: regulation by phosphate? Bone 35(5):1192–1199PubMedCrossRef

12.

Nishizawa Y, Jono S, Ishimura E, Shioi A (2005) Hyperphosphatemia and vascular calcification in end-stage renal disease. J Ren Nutr 15(1):178–182PubMedCrossRef

13.

Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y (2005) Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Life Sci 77(10):1130–1139PubMedCrossRef

14.

Inaba M, Okuno S, Kumeda Y, Yamakawa T, Ishimura E, Nishizawa Y (2005) Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus. Calcif Tissue Int 76(4):256–260PubMedCrossRef

15.

Inaba M, Okuno S, Imanishi Y, Ueda M, Yamakawa T, Ishimura E, Nishizawa Y (2005) Significance of Bio-intact PTH(1–84) assay in hemodialysis patients. Osteoporos Int 16(5):517–525PubMedCrossRef

16.

Inaba M, Nakatsuka K, Imanishi Y, Watanabe M, Mamiya Y, Ishimura E, Nishizawa Y (2004) Technical and clinical characterization of the Bio-PTH (1–84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone. Clin Chem 50(2):385–390PubMedCrossRef

17.

American Diabetes Association (2005) Mellitus TECotDaCoD. Report on the expert committee on the diagnosis and classification of diabetes mellitus. Diab Care 21(suppl 1):S5–S22

18.

Inaba M, Nagasue K, Okuno S, Ueda M, Kumeda Y, Imanishi Y, Shoji T, Ishimura E, Ohta T, Nakatani T, Kim M, Nishizawa Y (2002) Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Am J Kidney Dis 39(6):1261–1269PubMedCrossRef

19.

Gomez B Jr, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, Kung VT (1995) Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 41(11):1560–1566PubMed

20.

Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y (2000) Persistent increase in bone turnover in Graves’ patients with subclinical hyperthyroidism. J Clin Endocrinol Metab 85(11):4157–4161PubMedCrossRef

21.

Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M (1996) Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 16(8):978–983PubMed

22.

Edmonds ME (2000) Medial arterial calcification and diabetes mellitus. Z Kardiol 89(Suppl 2):101–104PubMedCrossRef

23.

Econs MJ, McEnery PT (1997) Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate wasting disorder. J Clin Endocrinol Metab 82(2):674–681PubMedCrossRef

24.

Miwa Y, Tsushima M, Arima H, Kawano Y, Sasaguri T (2004) Pulse pressure is an independent predictor for the progression of aortic wall calcification in patients with controlled hyperlipidemia. Hypertension 43(3):536–540PubMedCrossRef

25.

Wanner C, Zimmermann J, Schwedler S, Metzger T (2002) Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl 80:99–102PubMedCrossRef

26.

Arici M, Walls J (2001) End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 59(2):407–414PubMedCrossRef

27.

Sezer S, Ozdemir FN, Arat Z, Turan M, Habera M (2002) Triad of malnutrition, inflammation, and atherosclerosis in hemodialysis patients. Nephron 91(3):456–462PubMedCrossRef

28.

Benet-Pages A, Orlik P et al (2005) An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14(3):385–390PubMedCrossRef

29.

Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113(4):561–568PubMed

30.

Razzaque MS, St-Arnaud R, Taguchi T, Lanske B (2005) FGF-23, vitamin D and calcification: the unholy triad. Nephrol Dial Trans 20(10):2032–2035CrossRef

31.

Kimura K, Saika Y, Otani H, Fujii R, Mune M, Yukawa S (1999) Factors associated with calcification of the abdominal aorta in hemodialysis patients. Kidney Int 71(Suppl):S238–S241CrossRef

Title: Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients
Authors: M. Inaba
S. Okuno
Y. Imanishi
S. Yamada
A. Shioi
T. Yamakawa
E. Ishimura
Y. Nishizawa
Publication date: 01-10-2006
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 10/2006
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-006-0154-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients

Abstract

Introduction:

Methods:

Results:

Conclusion:

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction:

Methods:

Results:

Conclusion:

Please log in to get access to this content

Other articles of this Issue 10/2006

Correlation of transmenopausal bone mass in healthy white women: a long-term longitudinal study

The role of socioeconomic status on hip fracture

Spinal cord injury causes more damage to bone mass, bone structure, biomechanical properties and bone metabolism than sciatic neurectomy in young rats

Comparative study of axial and femoral bone mineral density and parameters of mandibular bone quality in patients receiving dental implants

Radiographic texture analysis of densitometer-generated calcaneus images differentiates postmenopausal women with and without fractures

Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats